Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
COAGULATION FACTOR IX HUMAN (UNII: 6U90Y1795T) (COAGULATION FACTOR IX HUMAN - UNII:6U90Y1795T)
Baxter Healthcare Corporation
COAGULATION FACTOR IX HUMAN
COAGULATION FACTOR IX HUMAN 300 [iU] in 1 mL
PRESCRIPTION DRUG
Biologic Licensing Application
BEBULIN VH- COAGULATION FACTOR IX HUMAN BAXTER HEALTHCARE CORPORATION ---------- BEBULIN VH (FACTOR IX COMPLEX), VAPOR HEATED DESCRIPTION BEBULIN VH (Factor IX Complex), Vapor Heated, (BEBULIN VH) is a purified, sterile, stable, freeze-dried concentrate of the coagulation Factors IX (Christmas Factor) as well as II (Prothrombin) and X (Stuart Prower Factor) and low amounts of Factor VII. In addition, the product contains small amounts of heparin (≤ 0.15 IU heparin per IU Factor IX). BEBULIN VH is standardized in terms of Factor IX content and each vial is labeled for the Factor IX content indicated in International Units (IU). One International Unit of Factor IX (according to the current International Standard for Human Blood Coagulation Factors II, IX, and X in Concentrates) corresponds to the activity of Factor IX in 1 mL of fresh normal human plasma. CLINICAL PHARMACOLOGY BEBULIN VH is a combination of vitamin K-dependent clotting factors found in normal plasma. The administration of BEBULIN VH provides an increase in plasma levels of Factor IX and can temporarily correct the coagulation defect of patients with Factor IX deficiency. Plasma levels of Factors II and X will also be increased. However, no clinical studies have been conducted to show benefit from this product for treating deficiencies other than Factor IX deficiency. _In vivo_ recovery of BEBULIN VH was determined by investigators in Germany, Japan, and the United States using the former International Standard, WHO 72/32 and was found to be 53.3% ±9.6%, 57.5% ±21.8%, and 53.24% ±16.95%, respectively. In the same studies, using different methodologies, half- lives were determined to be 19.4 hrs ±3.8 hrs, 24.6 hrs ±3.2 hrs, and 19.97 hrs ±8.24 hrs, respectively . During the manufacture BEBULIN VH is subjected to virus inactivation by two-step vapor heating at 60°C and 80°C , where BEBULIN VH intermediate bulk is heated for a total of 10 hours at >60°C and 1 hour at 80°C. Reduction factor for Parvovirus B19 claimed for the Lyophilization a Soma hati kamili